A neoplasm is an abnormal mass of tissue that forms when cells grow and divide more than they should, or when old cells that should die off keep living instead. The term covers a wide spectrum: neoplasms can be benign (not cancer), malignant (cancer), or somewhere in between. If you’ve seen this word on a lab report, radiology result, or medical bill, it’s essentially the medical term for “tumor,” and it doesn’t automatically mean cancer.
Neoplasm vs. Tumor vs. Cancer
These three words overlap, but they aren’t interchangeable in every context. “Neoplasm” and “tumor” mean the same thing in modern medicine: an abnormal growth of tissue. The National Cancer Institute lists them as synonyms. “Cancer,” on the other hand, refers only to malignant neoplasms, the ones that can invade nearby tissue or spread to distant parts of the body through the bloodstream or lymphatic system.
So every cancer is a neoplasm, but not every neoplasm is cancer. When a pathologist or billing coder uses the word “neoplasm,” they’re being precise without committing to a diagnosis of cancer until lab results confirm it.
Why Neoplasms Form
Your cells normally follow a tightly regulated cycle of growth, division, and death. Specialized proteins act as accelerators and brakes on this process, making sure cells divide only when needed and die when they’re damaged or old. A neoplasm develops when mutations disrupt that balance.
Some mutations cause growth-promoting proteins to become overactive, pushing cells to multiply faster than normal. Others knock out the “brake” proteins (known as tumor suppressors) that would ordinarily slow division or trigger damaged cells to self-destruct. Two of the most important regulatory proteins in this system are p53 and pRB. When both are compromised, cells can grow unchecked, accumulate further mutations, and eventually form a mass.
These mutations can be inherited, but most arise over a lifetime from environmental exposures, random copying errors during cell division, or a combination of both.
Benign Neoplasms
Benign neoplasms grow in place. They typically have well-defined borders, don’t invade surrounding tissue, and almost never spread to other parts of the body. Many grow slowly and cause no symptoms at all. They can, however, cause problems if they press on nerves, blood vessels, or organs, or if they produce hormones that throw the body off balance.
Some of the most common types include:
- Lipomas: lumps of fatty tissue just under the skin, and the single most common benign tumor overall
- Adenomas: slow-growing tumors in the tissue that lines organs and glands, sometimes found in the colon, thyroid, or pituitary gland
- Fibroids (myomas): growths in the muscular wall of the uterus, extremely common in women of reproductive age
- Hemangiomas: clusters of blood vessels that appear as red or purple bumps on or beneath the skin
- Meningiomas: tumors in the tissue surrounding the brain, usually slow-growing
- Osteomas: benign bone tumors
- Chondromas: tumors in cartilage, the flexible tissue that cushions joints
Most benign neoplasms need no treatment. When they do require removal, it’s usually because of their size, location, or symptoms rather than any risk of becoming cancerous.
Malignant Neoplasms
Malignant neoplasms are cancers. Their defining feature is the ability to invade surrounding tissue and, in many cases, spread (metastasize) to distant organs. Under a microscope, malignant cells look visibly different from normal cells: they divide rapidly, vary in size and shape, and have enlarged or misshapen nuclei.
Not all malignant neoplasms are equally aggressive. Low-grade malignancies have cells that still look somewhat normal, divide relatively slowly, and carry a lower risk of spreading (under 25% in some classification systems). High-grade malignancies look far more abnormal under the microscope, divide quickly, and are more likely to invade surrounding tissue or metastasize to distant sites.
In the United States, roughly 2.1 million new cancer cases are projected for 2026. The most common malignant neoplasms in men are prostate, lung, and colorectal cancers, which together account for nearly half of all diagnoses. In women, breast, lung, and colorectal cancers make up about 50% of new cases.
In Situ Neoplasms
Between clearly benign and clearly malignant, there’s a middle category that often confuses people on their pathology reports. An “in situ” neoplasm is one where the cells look abnormal, similar to cancer cells, but have not yet broken through the boundary layer (called the basement membrane) that separates the tissue’s surface from deeper structures. Think of it as a pre-invasive stage: the cells have changed, but they haven’t yet gained the ability to spread.
Carcinoma in situ is the most familiar example. It’s common in cervical, breast, and skin screenings. Because these growths can progress to invasive cancer over time, they’re typically treated or closely monitored even though they haven’t spread yet.
Neoplasms of Uncertain Behavior
Sometimes a pathologist examines a tumor under the microscope and genuinely cannot determine whether it will behave like a benign growth or a malignant one. These are classified as “neoplasms of uncertain behavior,” and they exist in a gray area. The cells may have some features suggesting malignancy but lack others, or the tumor type may simply not have a reliable track record for predicting outcomes.
When this label appears on a report, it doesn’t mean your doctors are unsure what to do. It means the treatment plan will be individualized based on the tumor’s size, location, and how concerning its features are. In many cases, the approach involves regular imaging and follow-up visits to watch for any changes over time. If the tumor starts showing more aggressive behavior, treatment can be adjusted accordingly.
What a Neoplasm Diagnosis Looks Like
If a neoplasm is found on imaging (an X-ray, CT scan, MRI, or ultrasound), the next step is usually a biopsy, where a small sample of the tissue is removed and examined under a microscope. The pathologist then classifies the growth using standardized coding systems that assign it a behavior category: benign, uncertain, in situ, or malignant. This classification determines what happens next, whether that’s watchful waiting, surgical removal, or a more involved treatment plan.
Seeing the word “neoplasm” on a medical document can feel alarming, but on its own, it tells you only that an abnormal growth was found. The word that follows it, benign, malignant, or uncertain, is the one that shapes your care.